Your EMS Partner's Executive Team
Executive Team and Investors
NVM Private Equity
Chemigraphic is backed by NVM Private Equity. NVM is independently owned with over 30 years’ experience of investing in unquoted UK businesses. NVM is a generalist investor, managing approximately £430 million of funds, and is differentiated by having executives living and working in regional business communities throughout the UK. Peter Hodson and David Rolfe led the investment for NVM and Peter joined the Chemigraphic board upon completion in June 2019.
NPI & Sales Systems Manager
Sales Operations Manager
Recent Blog Posts
Learn from the top thought leaders in the industry.
Going global: how international sourcing can improve the manufacturing process for electronic medical devices
How is the globalisation of the supply chain for components affecting the market for electronic medical devices? What opportunities does it offer? What effects will it have on the manufacturing process? What challenges can it solve? And what complications could it...
Last month the Cybersecurity and Infrastructure Security Agency (CISA) issued an advisory warning of vulnerabilities concerning several medical IoT devices that could lead to data breaches. These insecurities included buffer overflows, integer underflows, the improper...
Med-tech is booming. And while established market players continue to innovate and scale their businesses, the sheer numbers and stability of med-tech start-ups establishing themselves is sure to see a significant dint in the market share of the larger companies over...
Looking for Electronic Manufacturing Services?
We help our OEM customers to reduce their time to market and simplify their supply chain.